These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2690611)

  • 21. The renin system and new understanding of the complications of hypertension and their treatment.
    Laragh JH
    Arzneimittelforschung; 1993 Feb; 43(2A):247-54. PubMed ID: 8498972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superficial and juxtamedullary nephron function during converting enzyme inhibition.
    Göransson A; Sjöquist M; Ulfendahl HR
    Am J Physiol; 1986 Jul; 251(1 Pt 2):F25-33. PubMed ID: 3014898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.
    van Twist DJ; Houben AJ; de Haan MW; de Leeuw PW; Kroon AA
    J Hypertens; 2016 Jun; 34(6):1160-9. PubMed ID: 27032075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal hypertension following aortic constriction is abolished by angiotensin II converting enzyme inhibitor, but not by low-salt diet.
    Eklöf AC; Aperia A
    Acta Physiol Scand; 1990 Jul; 139(3):435-40. PubMed ID: 2239346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arterial hypertension, renal function and angiotensin-converting enzyme inhibition].
    Ribstein J; Mourad G; Mimran A
    Presse Med; 1988 Sep; 17(31):1578-82. PubMed ID: 2971959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal sodium metabolism and plasma renin activity (renal renin secretion) and the vasoconstriction volume hypothesis: implications for pathogenesis and treatment of hypertension and its vascular consequences (heart attack, stroke).
    Laragh JH; Sealey JE
    Clin Chem; 1991 Oct; 37(10 Pt 2):1820-7. PubMed ID: 1914196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin in the hemodynamic response to chronic nephron obstruction.
    Carmines PK; Tanner GA
    Am J Physiol; 1983 Jul; 245(1):F75-82. PubMed ID: 6346901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Normal and pathological renal aging in animals].
    Corman B
    Presse Med; 1992 Jul; 21(26):1238-45. PubMed ID: 1409479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW; Tucker BJ; Blantz RC
    J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Heller J; Kramer HJ; Horácek V
    Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.
    Lumbers ER; Burrell JH; Menzies RI; Stevens AD
    Br J Pharmacol; 1993 Oct; 110(2):821-7. PubMed ID: 8242257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
    Humke U; Levens N; Wood J; Hofbauer K
    J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.